Humana Inc. (HUM) Guidance & Earnings Results

On 2026-07-29 Humana Inc. mixed guidance: "FY26 Adjusted EPS at least $9.00 (affirmed); FY26 GAAP EPS at least $6.52 (revised from at least $8.36); FY26 Insurance segment benefit ratio 92.75% ±25 bps (affirmed); FY26 individual MA membership growth approximately…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HUMHumana Inc.Follow HUM — free

Healthcare Plans · Healthcare

—

Price chart with a free account

Market cap: 50.7B
P/E TTM: 39.9
Dividend yield: 0.8%
52-week: —
Next earnings: 6 Nov, in 13 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
29 Jul 26	Mixed	FY26 Adjusted EPS at least $9.00 (affirmed); FY26 GAAP EPS at least $6.52 (revised from at least $8.36); FY26 Insurance segment benefit ratio 92.75% ±25 bps (affirmed); FY26 individual MA membership growth approximately 25% over 2025 (affirmed) · full year
29 Apr 26	Reaffirmed	FY 2026 Adjusted EPS 'at least $9.00'; GAAP EPS 'at least $8.36' · full year
11 Feb 26	Lowered	FY2026 adjusted EPS at least $9.00 vs FY2025 $17.14
5 Nov 25	Lowered	GAAP EPS guidance cut to ~$12.26 from ~$13.77 · full year
30 Jul 25	Raised	FY2025 adjusted EPS raised to ~$17.00 from ~$16.25; FY2025 revenue raised to at least $128B from $126-128B; FY2025 GAAP EPS cut to ~$13.77 from ~$14.68; FY2025 benefit ratio affirmed 90.1-90.5%; MA membership decline improved to up to 500k from ~550k. · full year

Humana Inc. — questions

What guidance did Humana Inc. give?: On 2026-07-29: "FY26 Adjusted EPS at least $9.00 (affirmed); FY26 GAAP EPS at least $6.52 (revised from at least $8.36); FY26 Insurance segment benefit ratio 92.75% ±25 bps (affirmed); FY26 individual MA membership growth approximately 25% over 2025 (affirmed)"
When does Humana Inc. report earnings?: Humana Inc.'s next earnings report is expected on 2026-11-06.

Every figure on this page comes from Humana Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.